TickerFactsScreenerDevelopers

Avalo Therapeutics, Inc. (AVTX) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2012: $9.52M2013: $3.42M2014: $11.74M2015: $21.16M2016: $5.13M2017: $2.47M2018: $10.65M2019: $3.61M2020: $18.92M2021: $54.59M2022: $13.17M2023: $7.42M2024: $134.55M2025: $15.86M$15.86M
2012Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$15.86M-88.2%
2024$134.55M+1714.5%
2023$7.42M-43.7%
2022$13.17M-75.9%
2021$54.59M+188.5%
2020$18.92M+424.2%
2019$3.61M-66.1%
2018$10.65M+330.6%
2017$2.47M-51.8%
2016$5.13M-75.8%
2015$21.16M+80.2%
2014$11.74M+243.2%
2013$3.42M-64.1%
2012$9.52M—